Bloomberg Businessweek Weekend - August 1st, 2025
Bloomberg Businessweek
00:00
Path to Psychedelic Approval
This chapter delves into the journey towards FDA approval for psychedelic treatments aimed at mental health, particularly targeting treatment-resistant depression. It highlights a leading company's clinical trials utilizing psilocybin, showcasing promising results and the importance of safety in rigorous studies. The discussion includes regulatory challenges, potential broader access to treatment, and recent supportive engagement from government officials.
Transcript
Play full episode
